Kimia Biosciences [KIMIABL] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison

Kimia Biosciences

BSE

Sequent Scientific

NSE

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Kimia Biosciences wins in 8 metrics, Sequent Scientific wins in 6 metrics, with 0 ties. Kimia Biosciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Kimia Biosciences	Sequent Scientific	Better
P/E Ratio (TTM)	N/A	210.48	N/A
Price-to-Book Ratio	20.89	6.35	Sequent Scientific
Debt-to-Equity Ratio	394.92	62.47	Sequent Scientific
PEG Ratio	N/A	35.43	N/A
EV/EBITDA	12.86	30.33	Kimia Biosciences
Profit Margin (TTM)	8.08%	1.41%	Kimia Biosciences
Operating Margin (TTM)	19.09%	9.41%	Kimia Biosciences
EBITDA Margin (TTM)	19.09%	9.41%	Kimia Biosciences
Return on Equity	186.70%	4.35%	Kimia Biosciences
Return on Assets (TTM)	9.99%	4.01%	Kimia Biosciences
Free Cash Flow (TTM)	N/A	$442.70M	N/A
1-Year Return	-15.06%	22.29%	Sequent Scientific
Price-to-Sales Ratio (TTM)	1.84	2.89	Kimia Biosciences
Enterprise Value	$2.58B	$48.00B	Sequent Scientific
EV/Revenue Ratio	2.17	3.09	Kimia Biosciences
Gross Profit Margin (TTM)	N/A	50.28%	N/A
Revenue per Share (TTM)	$25	$62	Sequent Scientific
Earnings per Share (Diluted)	N/A	$0.85	N/A
Beta (Stock Volatility)	1.14	0.91	Sequent Scientific

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Kimia Biosciences vs Sequent Scientific Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Kimia Biosciences	-4.99%	-20.79%	-35.33%	10.03%	-6.90%	-1.94%
Sequent Scientific	-3.97%	-0.34%	-9.41%	8.30%	7.32%	-9.00%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Kimia Biosciences	-15.06%	10.69%	26.80%	120.00%	120.00%	120.00%
Sequent Scientific	22.29%	57.12%	26.68%	13.98%	13.98%	13.98%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Kimia Biosciences (KIMIABL): View Full Stock Overview

Sequent Scientific (SEQUENT): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Kimia Biosciences vs Sequent Scientific

Metric	KIMIABL	SEQUENT
Market Information
Market Cap i	₹2.19B	₹44.76B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	10,138	414,428
90 Day Avg. Volume i	24,617	471,488
Last Close	₹44.00	₹168.04
52 Week Range	₹35.10 - ₹86.85	₹117.35 - ₹240.70
% from 52W High	-49.34%	-30.19%
All-Time High	₹86.85 (Jul 02, 2025)	₹336.50 (Jun 28, 2021)
% from All-Time High	-49.34%	-50.06%
Growth Metrics
Quarterly Revenue Growth	0.26%	0.11%
Quarterly Earnings Growth	0.11%	0.12%
Financial Health
Profit Margin (TTM) i	0.08%	0.01%
Operating Margin (TTM) i	0.19%	0.09%
Return on Equity (TTM) i	1.87%	0.04%
Debt to Equity (MRQ) i	394.92	62.47
Cash & Liquidity
Book Value per Share (MRQ)	₹2.11	₹28.19
Cash per Share (MRQ)	₹0.04	₹2.52
Operating Cash Flow (TTM) i	₹213.14M	₹833.62M
Levered Free Cash Flow (TTM) i	₹54.08M	₹453.76M
Dividends
Last 12-Month Dividend Yield i	N/A	N/A
Last 12-Month Dividend i	N/A	₹0.00

Valuation & Enterprise Metrics Analysis: Kimia Biosciences vs Sequent Scientific

Metric	KIMIABL	SEQUENT
Price Ratios
P/E Ratio (TTM) i	N/A	210.48
Forward P/E i	N/A	35.43
PEG Ratio i	N/A	35.43
Price to Sales (TTM) i	1.84	2.89
Price to Book (MRQ) i	20.89	6.35
Market Capitalization
Market Capitalization i	₹2.19B	₹44.76B
Enterprise Value i	₹2.58B	₹48.00B
Enterprise Value Metrics
Enterprise to Revenue i	2.17	3.09
Enterprise to EBITDA i	12.86	30.33
Risk & Other Metrics
Beta i	1.14	0.91
Book Value per Share (MRQ) i	₹2.11	₹28.19

Financial Statements Comparison: Kimia Biosciences vs Sequent Scientific

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	KIMIABL	SEQUENT
Revenue/Sales i	N/A	₹4.02B
Cost of Goods Sold i	N/A	₹2.00B
Gross Profit i	N/A	₹2.02B
Research & Development i	N/A	N/A
Operating Income (EBIT) i	N/A	₹294.80M
EBITDA i	N/A	₹442.10M
Pre-Tax Income i	N/A	₹163.10M
Income Tax i	N/A	₹59.30M
Net Income (Profit) i	N/A	₹103.80M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	KIMIABL	SEQUENT
Cash & Equivalents i	N/A	₹626.60M
Total Current Assets i	N/A	₹8.74B
Total Current Liabilities i	N/A	₹5.05B
Long-Term Debt i	N/A	₹3.00B
Total Shareholders Equity i	N/A	₹7.70B
Retained Earnings i	N/A	N/A
Property, Plant & Equipment i	N/A	₹2.84B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	KIMIABL	SEQUENT
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	KIMIABL	SEQUENT
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	10,138	414,428
Average Daily Volume (90 Day) i	24,617	471,488
Shares Outstanding i	47.31M	249.89M
Float Shares i	3.80M	117.77M
% Held by Insiders i	0.92%	0.53%
% Held by Institutions i	0.00%	0.13%

Dividend Analysis & Yield Comparison: Kimia Biosciences vs Sequent Scientific

Metric	KIMIABL	SEQUENT
Last 12-Month Dividend i	N/A	₹0.00
Last 12-Month Dividend Yield i	N/A	N/A
3-Year Avg Annual Dividend i	N/A	₹0.00
3-Year Avg Dividend Yield i	N/A	N/A
3-Year Total Dividends i	N/A	₹0.00
Ex-Dividend Date	N/A	N/A

Kimia Biosciences [KIMIABL] vs Sequent Scientific [SEQUENT] Detailed Stock Comparison